Trump's 100% Pharmaceutical Tariffs: Potential Impact on India's $8.7 Billion US Drug Exports

Sep 26, 2025 01:18 pm CST

US President Donald Trump has announced 100% tariffs on branded and patented pharmaceutical imports starting October 1, 2025, unless companies build manufacturing facilities in America. This decision could significantly impact India's pharmaceutical sector, which exported $8.7 billion in medicines to the US in FY24, representing 31% of India's total pharma exports. With Indian companies supplying 45% of US generic drugs, both nations face potential consequences including price increases and supply disruptions.